Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 239-362-1 | CAS number: 15332-99-7
Endpoint summary
Administrative data
Description of key information
Key value for chemical safety assessment
Acute toxicity: via oral route
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 18 000 mg/kg bw
Acute toxicity: via inhalation route
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LC50
- Value:
- 4 310 mg/m³ air
Acute toxicity: via dermal route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
Tris(isopropenyloxy)(vinyl)silane has been tested for acute oral toxicity according to OECD 401 (TNO, 1983); there is no information on GLP compliance. The following clinical signs were observed after ten male and ten female Wistar rats were dosed with 20 ml/kg bw: sluggishness, ataxia and rough coats. A single male died on the second day. It is concluded that the LD50 is >20 ml/kg bw, which is equivalent to approximately 18000 mg/kg, based on a density of 0.9 g/cm3.
Tris(isopropenyloxy)(vinyl)silane has been tested for acute inhalation (aerosol) toxicity in rats in a study conducted according to OECD 403 and in compliance with GLP (RCC, 1989). No mortalities occurred, and treatment-related effects were confined to piloerection and apathy on the day after administration, in the five male and five female rats treated with an aerosol containing 4.31 mg/l of the test substance. It is concluded that the LD50 is >4.31 mg/l under the conditions of the test.
Justification for selection of acute toxicity – oral endpoint
The study was conducted according to a protocol similar to an appropriate OECD guideline. There is no information on GLP compliance.
Justification for selection of acute toxicity – inhalation endpoint
The study was conducted according to an appropriate OECD guideline and in compliance with GLP.
Justification for classification or non-classification
Based on the available studies on acute toxicity, tris(isopropenyloxy)(vinyl)silane does not require classification according to Regulation (EC) No. 1272/2008.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
